DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension

(2015) C.H. Santuzzi et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat

(2014) Ravi Nistala et al.   Obesity

Standards of Medical Care in Diabetes--2014

(2013)   DIABETES CARE

Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats

(2013) Annayya R. Aroor et al.   ENDOCRINOLOGY

Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway

(2013) Yong Zhang et al.   HYPERTENSION RESEARCH

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia

(2013) Lorena M. Amaral et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney

(2013) Kwon Wook Joo et al.   BMC Nephrology

Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl4-induced oxidative stress in the thyroid tissue of rats

(2012) Rahmat Ali Khan   BMC Complementary and Alternative Medicine

Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats

(2012) Thangarasu Silambarasan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy

(2012) Elen Rizzi et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

(2012) Limei Liu et al.   HYPERTENSION

Ferulic Acid Improves Cardiovascular and Kidney Structure and Function in Hypertensive Rats

(2012) Md. Ashraful Alam et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)

(2011) Cristina Mega et al.   Experimental Diabetes Research

Angiotensin II induces inflammation leading to cardiac remodeling

(2011) Lixin Jia   Frontiers in Bioscience-Landmark

Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

(2010) Annis Marney et al.   HYPERTENSION

Genistein Prevents Myocardial Hypertrophy in 2-Kidney 1-Clip Renal Hypertensive Rats by Restoring eNOS Pathway

(2010) Jie Li et al.   PHARMACOLOGY

Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes

(2010) Jitendra Vaghasiya et al.   REGULATORY PEPTIDES

Pathogenic perspectives for the role of inflammation in diabetic nephropathy

(2009) Antonio Rivero et al.   CLINICAL SCIENCE

Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis

(2009) G. M. Magee et al.   DIABETOLOGIA

Kidney Fibrosis in Hypertensive Rats: Role of Oxidative Stress

(2008) Wenyuan Zhao et al.   AMERICAN JOURNAL OF NEPHROLOGY

Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

(2008) J. M. Forbes et al.   DIABETES

NADPH oxidases and angiotensin II receptor signaling

(2008) Abel Martin Garrido et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY